期刊文献+

140例药品不良反应报告与成本分析 被引量:4

Analysis of 140 Cases of Adverse Drug Reaction Reports and Cost
下载PDF
导出
摘要 目的分析药品不良反应及其治疗成本,为指导临床合理用药,减少医药费用的支出提供科学依据。方法采用回顾性分析方法,对140例因药品不良反应报告造成的直接费用和间接费用进行分析。结果 140例药品不良反应病例中,主要为抗感染药物(50.71%),其次为心脑血管药(12.14%),ADR主要表现是皮肤及其附件损害,其次是消化系统、神经系统。每例平均治疗时间为2.69天,平均每例患者因药品不良反应导致的直接成本费用为112.11元,间接费用为100.10元。结论通过对药品不良反应治疗成本分析,药品不良反应(ADR)的发生给患者和社会带来了沉重的经济负担,应更多地进行ADR经济成本的监测工作,并采取相应措施,减轻社会和患者的ADR成本负担。 Objective Analysis of adverse drug reaction and their treatment costs for clinical therapy to reduce the medical expenses the cost of providing a scientific basis.Methods Retrospective analysis of 140 cases of adverse drug reaction caused by the direct costs and indirect costs were analyzed.Results 140 cases of adverse drug reaction cases.Mainly for anti-infective drugs(50.71%),followed by cardiovascular drugs(12.14%),ADR mainly the skin and appendages,was followed by the digestive system,nervous system.The average treatment time per patient is 2.69 days per patient due to adverse drug reaction due to the direct cost to 112.11 yuan,an indirect cost of 100.10 yuan.Conclusion Based on the analysis of treatment costs of adverse drug reaction,ADR occurred to patients and society of the heavy financial burden,should be greater monitoring of economic costs of ADR,and to take measures to mitigate the social costs and patients ADR.
作者 陈崇泽
出处 《中国药物警戒》 2010年第9期561-563,共3页 Chinese Journal of Pharmacovigilance
关键词 药品不良反应 成本 分析 adverse drug reaction(ADR) cost analysis
  • 相关文献

参考文献6

  • 1Piontek F,Kohli R,Conlon P,et al.Effects of an adverse-drug-event alert system on cost and quality outcomes in community hospitals[J].Am J Health Syst Pharm,2010,67(8):613-620.
  • 2Izquierdo E,Rodr í guez C,Pampliega E.et al.Determination of the frequency and direct cost of the adverse drug events in Argentina[J].Current drug safety,2009,4(2):103-106.
  • 3Chan ALF,Lee,H Y,Ho,CH.et al.Cost evaluation of adverse drug reactions in hospitalized patients in Taiwan:A prospective,descriptive,observational study[J].Current Therapeutic Research,2008,69(2):118-129.
  • 4Kane-Gili S,Rea R S,Verrico MM.et al.Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit[J].Am J Health Syst Pharm,2006,63(19):1876-81.
  • 52009年福州市国民经济和社会发展统计公报[EB/OL].2010-03-24[2010-5-23].http://www.fuzhou.gov.cn/tjj/njdtjsj/201003/t20100324_119787.htm.
  • 6林阳,陈燕.围手术期抗菌药物预防性应用的调查[J].药物不良反应杂志,2006,8(3):181-184. 被引量:21

二级参考文献2

共引文献20

同被引文献68

  • 1孟玉芳,茅宁莹.药物经济学在我国医药产业的应用与发展趋势[J].中国现代药物应用,2007,1(2):30-31. 被引量:2
  • 2赵林海,陈飞虎,刘国旗.药物不良反应社会成本控制最优化的经济学分析[J].医学与哲学,2005,26(10S):56-57. 被引量:5
  • 3蒙志莹,顾海.药品不良反应经济学研究初探[J].中国药房,2005,16(20):1528-1530. 被引量:13
  • 4刘洁,顾海.药品不良反应成本测算研究[J].卫生经济研究,2007,24(2):18-19. 被引量:13
  • 5Lundkvist J, Jonsson B. Pharmacoeconomics of adverse drug reactions. Fundamental & Clinical Pharmacology,2004,18:275-280.
  • 6Visconti JA, Smith MC. The economics of adverse drug reactions-case studies. Ann Pharmacother,2006 ,40 :529-536.
  • 7Blomqvist P, Feltelius N, Lfberg R, et al. A 10-year survey of inflamma tory bowel diseases-drug therapy, costs and adverse reactions. Alimentary Pharmacology & Therapeutics,2001,15:475-481.
  • 8Sullivan PW, Valuck R, Saseen J,et al. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse Drug reactions. CNS drugs ,2004,18:911-932.
  • 9Janaje Munasinghe TM, Singer DR. Costs and prevention of adverse drug reactions. European Journal of Internal Medicine,2001,12:403-405.
  • 10McIntosh E. The cost of rheumatoid arthritis. British Journal of Rheumatology, 1996,35:781-790.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部